We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Molecular pathways of neurodegeneration in Parkinson's disease.
- Authors
Dawson, Ted M; Dawson, Valina L
- Abstract
Parkinson's disease (PD) is a complex disorder with many different causes, yet they may intersect in common pathways, raising the possibility that neuroprotective agents may have broad applicability in the treatment of PD. Current evidence suggests that mitochondrial complex I inhibition may be the central cause of sporadic PD and that derangements in complex I cause alpha-synuclein aggregation, which contributes to the demise of dopamine neurons. Accumulation and aggregation of alpha-synuclein may further contribute to the death of dopamine neurons through impairments in protein handling and detoxification. Dysfunction of parkin (a ubiquitin E3 ligase) and DJ-1 could contribute to these deficits. Strategies aimed at restoring complex I activity, reducing oxidative stress and alpha-synuclein aggregation, and enhancing protein degradation may hold particular promise as powerful neuroprotective agents in the treatment of PD.
- Publication
Science (New York, N.Y.), 2003, Vol 302, Issue 5646, p819
- ISSN
1095-9203
- Publication type
Journal Article
- DOI
10.1126/science.1087753